Syndrome des mouvements périodiques nocturnes des membres : Questions médicales fréquentes
Nom anglais: Nocturnal Myoclonus Syndrome
Descriptor UI:D020189
Tree Number:C10.886.659.618
Termes MeSH sélectionnés :
Myopia
Questions fréquentes et termes MeSH associés
Diagnostic
5
#1
Comment diagnostique-t-on ce syndrome ?
Le diagnostic repose sur l'observation des mouvements nocturnes et des études du sommeil.
Syndrome des mouvements périodiquesPolysomnographie
#2
Quels tests sont utilisés pour le diagnostic ?
La polysomnographie est le test principal pour évaluer les mouvements et les cycles de sommeil.
PolysomnographieTroubles du sommeil
#3
Quels critères sont utilisés pour le diagnostic ?
Les critères incluent la fréquence des mouvements et leur impact sur la qualité du sommeil.
Syndrome des mouvements périodiquesQualité du sommeil
#4
Le syndrome est-il confondu avec d'autres troubles ?
Oui, il peut être confondu avec le syndrome des jambes sans repos ou d'autres troubles du sommeil.
Syndrome des jambes sans reposTroubles du sommeil
#5
Les antécédents médicaux influencent-ils le diagnostic ?
Oui, des antécédents de troubles du sommeil ou neurologiques peuvent influencer le diagnostic.
Antécédents médicauxTroubles neurologiques
Symptômes
5
#1
Quels sont les symptômes principaux ?
Les symptômes incluent des mouvements involontaires des membres et des réveils fréquents.
Mouvements involontairesRéveils nocturnes
#2
Les mouvements se produisent-ils à des moments précis ?
Oui, ils se produisent généralement pendant les phases de sommeil léger.
Phases de sommeilSommeil léger
#3
Y a-t-il des douleurs associées aux mouvements ?
Les mouvements peuvent causer des douleurs ou de l'inconfort, perturbant le sommeil.
DouleurPerturbation du sommeil
#4
Les symptômes varient-ils d'une personne à l'autre ?
Oui, l'intensité et la fréquence des mouvements peuvent varier considérablement.
Variabilité des symptômesTroubles du sommeil
#5
Les symptômes affectent-ils la qualité de vie ?
Oui, ils peuvent entraîner une fatigue diurne et affecter la qualité de vie globale.
Fatigue diurneQualité de vie
Prévention
5
#1
Peut-on prévenir ce syndrome ?
Il n'existe pas de méthode de prévention garantie, mais une bonne hygiène du sommeil peut aider.
PréventionHygiène du sommeil
#2
Le stress influence-t-il le syndrome ?
Oui, le stress peut aggraver les symptômes, donc la gestion du stress est conseillée.
StressGestion du stress
#3
L'alimentation joue-t-elle un rôle ?
Une alimentation équilibrée peut contribuer à un meilleur sommeil et réduire les symptômes.
Alimentation équilibréeSommeil
#4
L'exercice physique aide-t-il ?
Oui, l'exercice régulier peut améliorer la qualité du sommeil et réduire les mouvements nocturnes.
Exercice physiqueQualité du sommeil
#5
Les habitudes de sommeil influencent-elles le syndrome ?
Oui, des habitudes de sommeil régulières peuvent aider à réduire l'incidence des mouvements.
Habitudes de sommeilMouvements nocturnes
Traitements
5
#1
Quels traitements sont disponibles ?
Les traitements incluent des médicaments comme les benzodiazépines et des thérapies comportementales.
BenzodiazépinesThérapies comportementales
#2
Les changements de mode de vie aident-ils ?
Oui, des changements comme une meilleure hygiène du sommeil peuvent réduire les symptômes.
Hygiène du sommeilChangements de mode de vie
#3
Les médicaments sont-ils toujours nécessaires ?
Pas toujours, certains patients peuvent gérer les symptômes avec des approches non médicamenteuses.
Approches non médicamenteusesGestion des symptômes
#4
Y a-t-il des effets secondaires aux traitements ?
Oui, certains médicaments peuvent provoquer des effets secondaires comme la somnolence.
Effets secondairesSomnolence
#5
Les traitements sont-ils efficaces à long terme ?
L'efficacité peut varier, et un suivi régulier est souvent nécessaire pour ajuster le traitement.
Suivi médicalEfficacité des traitements
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent la fatigue chronique et des troubles de l'humeur comme l'anxiété.
Fatigue chroniqueTroubles de l'humeur
#2
Le syndrome peut-il affecter la santé mentale ?
Oui, les troubles du sommeil peuvent contribuer à des problèmes de santé mentale.
Santé mentaleTroubles du sommeil
#3
Y a-t-il un risque accru d'autres maladies ?
Oui, les troubles du sommeil peuvent augmenter le risque de maladies cardiovasculaires.
Maladies cardiovasculairesTroubles du sommeil
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie.
RéversibilitéTraitement
#5
Comment les complications sont-elles gérées ?
La gestion des complications implique souvent une approche multidisciplinaire incluant médecins et psychologues.
Gestion des complicationsApproche multidisciplinaire
Facteurs de risque
5
#1
Quels sont les facteurs de risque connus ?
Les facteurs incluent l'âge avancé, des troubles neurologiques et des antécédents familiaux.
Âge avancéAntécédents familiaux
#2
Le sexe influence-t-il le risque ?
Oui, les hommes sont souvent plus touchés que les femmes par ce syndrome.
SexePrévalence
#3
Les troubles du sommeil augmentent-ils le risque ?
Oui, des troubles comme l'apnée du sommeil peuvent augmenter le risque de ce syndrome.
Apnée du sommeilTroubles du sommeil
#4
Les médicaments peuvent-ils être un facteur de risque ?
Oui, certains médicaments, comme les antidépresseurs, peuvent exacerber les symptômes.
AntidépresseursFacteurs de risque
#5
Le mode de vie influence-t-il le risque ?
Oui, un mode de vie sédentaire et une mauvaise hygiène du sommeil peuvent augmenter le risque.
Mode de vie sédentaireHygiène du sommeil
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des mouvements périodiques nocturnes des membres : Questions médicales les plus fréquentes",
"headline": "Syndrome des mouvements périodiques nocturnes des membres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des mouvements périodiques nocturnes des membres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des mouvements périodiques nocturnes des membres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D009422",
"about": {
"@type": "MedicalCondition",
"name": "Maladies du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des mouvements périodiques nocturnes des membres",
"alternateName": "Nocturnal Myoclonus Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D020189",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sterre van der Veen",
"url": "https://questionsmedicales.fr/author/Sterre%20van%20der%20Veen",
"affiliation": {
"@type": "Organization",
"name": "Pontificia Universidad Católica Argentina (UCA) Buenos Aires Argentina."
}
},
{
"@type": "Person",
"name": "Marina A J Tijssen",
"url": "https://questionsmedicales.fr/author/Marina%20A%20J%20Tijssen",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology University of Groningen, University Medical Center Groningen Groningen The Netherlands."
}
},
{
"@type": "Person",
"name": "Matthew R Epstein",
"url": "https://questionsmedicales.fr/author/Matthew%20R%20Epstein",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York."
}
},
{
"@type": "Person",
"name": "Kyle P Michelson",
"url": "https://questionsmedicales.fr/author/Kyle%20P%20Michelson",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York."
}
},
{
"@type": "Person",
"name": "Thomas F Monaghan",
"url": "https://questionsmedicales.fr/author/Thomas%20F%20Monaghan",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Epidemiology of Myopia: Prevalence, Risk Factors and Effects of Myopia.",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39384213",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2340-1790"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of myopia-associated genes in a Han Chinese population with high myopia.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37165999",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13816810.2023.2191709"
}
},
{
"@type": "ScholarlyArticle",
"name": "Extreme myopia is more susceptible to SOX2 gene than high myopia.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36921835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exer.2023.109435"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prevalence of myopia and uncorrected myopia among 721 032 schoolchildren in a city-wide vision screening in southern China: the Shantou Myopia Study.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/36198476",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bjo-2021-320940"
}
},
{
"@type": "ScholarlyArticle",
"name": "EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36708714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17434440.2023.2174429"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndrome des mouvements périodiques nocturnes des membres",
"item": "https://questionsmedicales.fr/mesh/D020189"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des mouvements périodiques nocturnes des membres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Comment diagnostique-t-on ce syndrome ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe syndrome est-il confondu avec d'autres troubles ?\nLes antécédents médicaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Myopia#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quels sont les symptômes principaux ?\nLes mouvements se produisent-ils à des moments précis ?\nY a-t-il des douleurs associées aux mouvements ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Myopia#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Peut-on prévenir ce syndrome ?\nLe stress influence-t-il le syndrome ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il ?\nLes habitudes de sommeil influencent-elles le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Myopia#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quels traitements sont disponibles ?\nLes changements de mode de vie aident-ils ?\nLes médicaments sont-ils toujours nécessaires ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils efficaces à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Myopia#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quelles complications peuvent survenir ?\nLe syndrome peut-il affecter la santé mentale ?\nY a-t-il un risque accru d'autres maladies ?\nLes complications sont-elles réversibles ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Myopia#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nLes troubles du sommeil augmentent-ils le risque ?\nLes médicaments peuvent-ils être un facteur de risque ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Myopia#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on ce syndrome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'observation des mouvements nocturnes et des études du sommeil."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La polysomnographie est le test principal pour évaluer les mouvements et les cycles de sommeil."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence des mouvements et leur impact sur la qualité du sommeil."
}
},
{
"@type": "Question",
"name": "Le syndrome est-il confondu avec d'autres troubles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec le syndrome des jambes sans repos ou d'autres troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles du sommeil ou neurologiques peuvent influencer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires des membres et des réveils fréquents."
}
},
{
"@type": "Question",
"name": "Les mouvements se produisent-ils à des moments précis ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils se produisent généralement pendant les phases de sommeil léger."
}
},
{
"@type": "Question",
"name": "Y a-t-il des douleurs associées aux mouvements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mouvements peuvent causer des douleurs ou de l'inconfort, perturbant le sommeil."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la fréquence des mouvements peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner une fatigue diurne et affecter la qualité de vie globale."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir ce syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais une bonne hygiène du sommeil peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le syndrome ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes, donc la gestion du stress est conseillée."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut contribuer à un meilleur sommeil et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la qualité du sommeil et réduire les mouvements nocturnes."
}
},
{
"@type": "Question",
"name": "Les habitudes de sommeil influencent-elles le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de sommeil régulières peuvent aider à réduire l'incidence des mouvements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments comme les benzodiazépines et des thérapies comportementales."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements comme une meilleure hygiène du sommeil peuvent réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils toujours nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains patients peuvent gérer les symptômes avec des approches non médicamenteuses."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent provoquer des effets secondaires comme la somnolence."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité peut varier, et un suivi régulier est souvent nécessaire pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fatigue chronique et des troubles de l'humeur comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il affecter la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil peuvent contribuer à des problèmes de santé mentale."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru d'autres maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications implique souvent une approche multidisciplinaire incluant médecins et psychologues."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, des troubles neurologiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont souvent plus touchés que les femmes par ce syndrome."
}
},
{
"@type": "Question",
"name": "Les troubles du sommeil augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme l'apnée du sommeil peuvent augmenter le risque de ce syndrome."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les antidépresseurs, peuvent exacerber les symptômes."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise hygiène du sommeil peuvent augmenter le risque."
}
}
]
}
]
}
From the Children's Neurosciences (T.R., M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre; Department Women and Children's Health (T.R., M.L.), School of Life Course Sciences (SoLCS), King's College London, UK; Division of Neurology (E.A.Y.), Department of Pediatrics, Neurosciences and Mental Health (RI), The Hospital for Sick Children; Faculty of Medicine (E.A.Y.), The University of Toronto, Ontario, Canada; Department of Pediatrics (Y.K.) and Department of Neurology (Y.K.), Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics (Y.K.), Weill Medical College of Cornell University, New York; Children and Young People's Unit (Paola Angelini), The Royal Marsden, Downs Road, Sutton, Surrey; UCL Great Ormond Street Institute of Child Health (C.H.), Department of Neurology, Great Ormond Street Hospital for Children, London; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, UK; SiRIC RTOP (G.S.), Translational Research Department, PSL Research University, Institut Curie Research Center; INSERM U830 (G.S.), PSL Research University, Institut Curie Research Center; SIREDO Center: Care (G.S.), Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France; Department of Child and Adolescent Psychiatry (P.S.), King's College London; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) Research Team (P.S.), South London and Maudsley NHS Foundation Trust, London, UK; Baylor College of Medicine (T.L.), Texas Children's Hospital, Houston; Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Westmead, NSW, Australia; TY Nelson Department of Neurology and Neurosurgery (R.C.D.), The Children's Hospital at Westmead; The Children's Hospital at Westmead Clinical School (R.C.D.), Faculty of Medicine, University of Sydney, NSW, Australia; Pediatric Neurology Department (K.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Bicêtre Hospital; National Referral Center for Rare Inflammatory and Auto-Immune Brain and Spinal Diseases (K.D.); Inserm UMR 1184 (K.D.), Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France; Department of Pediatric Hematology and Oncology (B.H.), University Children's Hospital, Koln; Division of Child Neurology (A.K.), University Children's Hospital Bern Inselspital, University of Bern; Department of Pediatric Neurology (A.K.), University Children's Hospital Basel, Switzerland; Department of Pediatrics (Pedro de Alarcon), University of Illinois College of Medicine at Peoria, Peoria IL; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, MA; Division of Neurology (W.G.M.), Department of Pediatrics, Children's Hospital Los Angeles; and Department of Neurology (W.G.M.), Keck School of Medicine at the University of Southern California, Los Angeles.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
From the Children's Neurosciences (T.R., M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre; Department Women and Children's Health (T.R., M.L.), School of Life Course Sciences (SoLCS), King's College London, UK; Division of Neurology (E.A.Y.), Department of Pediatrics, Neurosciences and Mental Health (RI), The Hospital for Sick Children; Faculty of Medicine (E.A.Y.), The University of Toronto, Ontario, Canada; Department of Pediatrics (Y.K.) and Department of Neurology (Y.K.), Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics (Y.K.), Weill Medical College of Cornell University, New York; Children and Young People's Unit (Paola Angelini), The Royal Marsden, Downs Road, Sutton, Surrey; UCL Great Ormond Street Institute of Child Health (C.H.), Department of Neurology, Great Ormond Street Hospital for Children, London; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, UK; SiRIC RTOP (G.S.), Translational Research Department, PSL Research University, Institut Curie Research Center; INSERM U830 (G.S.), PSL Research University, Institut Curie Research Center; SIREDO Center: Care (G.S.), Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France; Department of Child and Adolescent Psychiatry (P.S.), King's College London; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) Research Team (P.S.), South London and Maudsley NHS Foundation Trust, London, UK; Baylor College of Medicine (T.L.), Texas Children's Hospital, Houston; Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Westmead, NSW, Australia; TY Nelson Department of Neurology and Neurosurgery (R.C.D.), The Children's Hospital at Westmead; The Children's Hospital at Westmead Clinical School (R.C.D.), Faculty of Medicine, University of Sydney, NSW, Australia; Pediatric Neurology Department (K.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Bicêtre Hospital; National Referral Center for Rare Inflammatory and Auto-Immune Brain and Spinal Diseases (K.D.); Inserm UMR 1184 (K.D.), Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France; Department of Pediatric Hematology and Oncology (B.H.), University Children's Hospital, Koln; Division of Child Neurology (A.K.), University Children's Hospital Bern Inselspital, University of Bern; Department of Pediatric Neurology (A.K.), University Children's Hospital Basel, Switzerland; Department of Pediatrics (Pedro de Alarcon), University of Illinois College of Medicine at Peoria, Peoria IL; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, MA; Division of Neurology (W.G.M.), Department of Pediatrics, Children's Hospital Los Angeles; and Department of Neurology (W.G.M.), Keck School of Medicine at the University of Southern California, Los Angeles.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
From the Children's Neurosciences (T.R., M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre; Department Women and Children's Health (T.R., M.L.), School of Life Course Sciences (SoLCS), King's College London, UK; Division of Neurology (E.A.Y.), Department of Pediatrics, Neurosciences and Mental Health (RI), The Hospital for Sick Children; Faculty of Medicine (E.A.Y.), The University of Toronto, Ontario, Canada; Department of Pediatrics (Y.K.) and Department of Neurology (Y.K.), Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics (Y.K.), Weill Medical College of Cornell University, New York; Children and Young People's Unit (Paola Angelini), The Royal Marsden, Downs Road, Sutton, Surrey; UCL Great Ormond Street Institute of Child Health (C.H.), Department of Neurology, Great Ormond Street Hospital for Children, London; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, UK; SiRIC RTOP (G.S.), Translational Research Department, PSL Research University, Institut Curie Research Center; INSERM U830 (G.S.), PSL Research University, Institut Curie Research Center; SIREDO Center: Care (G.S.), Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France; Department of Child and Adolescent Psychiatry (P.S.), King's College London; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) Research Team (P.S.), South London and Maudsley NHS Foundation Trust, London, UK; Baylor College of Medicine (T.L.), Texas Children's Hospital, Houston; Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Westmead, NSW, Australia; TY Nelson Department of Neurology and Neurosurgery (R.C.D.), The Children's Hospital at Westmead; The Children's Hospital at Westmead Clinical School (R.C.D.), Faculty of Medicine, University of Sydney, NSW, Australia; Pediatric Neurology Department (K.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Bicêtre Hospital; National Referral Center for Rare Inflammatory and Auto-Immune Brain and Spinal Diseases (K.D.); Inserm UMR 1184 (K.D.), Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France; Department of Pediatric Hematology and Oncology (B.H.), University Children's Hospital, Koln; Division of Child Neurology (A.K.), University Children's Hospital Bern Inselspital, University of Bern; Department of Pediatric Neurology (A.K.), University Children's Hospital Basel, Switzerland; Department of Pediatrics (Pedro de Alarcon), University of Illinois College of Medicine at Peoria, Peoria IL; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, MA; Division of Neurology (W.G.M.), Department of Pediatrics, Children's Hospital Los Angeles; and Department of Neurology (W.G.M.), Keck School of Medicine at the University of Southern California, Los Angeles.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
From the Department of Neurology (J.D.S.), Massachusetts General Hospital, Boston; Department of Neurology (J.D.S., J.M.K., M.P.G.), Boston Children's Hospital, MA; Harvard Medical School (J.D.S., K.D.M.), Boston, MA; Division of Neurology (J.D.S.), Department of Pediatrics, Children's Hospital of Los Angeles, CA; Department of Neurology (J.D.S.), Keck School of Medicine at the University of Southern California, Los Angeles; Department of Pediatrics (R.C., T.C.C.), University of Utah School of Medicine, Salt Lake City; Department of Neurology and Neurotherapeutics (B.M.G.), The University of Texas Southwestern Medical Center at Dallas, TX; UCSF Weill Institute for Neurosciences (E.W.), Department of Neurology, University of California San Francisco, CA; Computational Health Informatics Program (S.W.K., K.D.M.), Boston Children's Hospital, MA; and Department of Pediatrics (S.W.K., K.D.M.), Boston Children's Hospital, MA. jdsantoro@chla.usc.edu.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
Myopia is the most common cause of visual impairment in children and young adults. In order to assess the consequences for society, it is necessary to know temporal trends in prevalence, incidence and...
High myopia is a leading cause of blindness worldwide. However, the exact etiology and mechanism of high myopia remain unclear. Previous genome-wide association study has demonstrated that nine single...
Seven SNPs were genotyped by the MassARRAY iPLEX Gold method in a Han Chinese cohort with the majority from Henan region (central China), which included 361 patients with high myopia and 749 healthy c...
In terms of genotyped SNPs, the allele frequency of rs698047 locus of the HIVEP3 gene were statistically different between myopia and control groups initially, but the difference disappeared after Bon...
There was no demonstrated association between the occurrence of high myopia in the Chinese Han population and polymorphisms in the following loci: HIVEP3 (rs698047), NFASC/CNTN2 (rs2246661), ZC3H11B (...
To explore the association between two single-nucleotide polymorphisms (SNPs) in the SOX2 gene and high and extreme myopia in the Han Chinese population....
A genetic association study using a case-control method was performed with 139 high myopia, 318 extreme myopia, and 918 healthy participants from the Chinese Han population. Two SNPs (rs4459940 and rs...
The mean ages of the extreme myopia and control subjects were 47.44 ± 15.59 and 44.15 ± 14.08 years, respectively. The rs4575941 SNP of the SOX2 gene and the GG and AG genotypes showed no significant ...
The SOX2 rs4575941 polymorphism, in Chinese Han population, contributes to the susceptibility of extreme myopia. SOX2 may thus be implicated in extreme myopia rather than in high myopia....
To explore the prevalence and risk factors for myopia and uncorrected myopia in schoolchildren in southern China....
The government-led Shantou Myopia Study was conducted from September 2020 to June 2021. Non-cycloplegic refraction was performed. Uncorrected visual acuity (UCVA) was measured along with presenting vi...
This study enrolled 724 828 schoolchildren (77.8% of all schoolchildren in Shantou) from 901 schools. Data from 721 032 schoolchildren (99.5%) were analysed (mean age 11.53±3.13 years, 6-20 years, 373...
The overall prevalence of myopia among schoolchildren in Shantou was 51.8%, higher than the national average in China. The proportion of uncorrected myopia is high, especially in primary schools. Our ...
Intraocular lens implantation in phakic eyes for the correction of refractive error is currently a widespread procedure. The EVO and EVO+ Visian Implantable Collamer Lenses (ICL) are two of the most p...
During the last decade, more than 100 scientific papers analyzing the performance of EVO and EVO+ lenses have been published. This review describes the objective visual performance achieved with the i...
Refractive surgeons and candidates to undergo ICL implantation should be aware of the excellent safety and visual outcomes provided by the implantation of central hole ICL lenses. However, future rese...
Initial studies have suggested that multiple segment (MS) spectacle lenses can reduce the progression rate of childhood myopia and axial eye growth. This paper aimed to compare the effectiveness of tw...
Published data from the only two clinical trials in which changes in mean spherical equivalent refraction (SER) and axial length (AL) for matched groups of myopic children wearing either MS or single-...
Absolute changes in SER and AL differed over time during the two trials. However, if the results were expressed in terms of efficacy over successive 6-month periods, then the two MS lenses produced br...
Myopia control may be due to either the additional myopic defocus induced by the MS lenses (i.e., asymmetry of the through-focus image changes about the distance focus) or to the general reduction in ...
Multiple segment spectacle lenses offer a valuable new approach to the control of myopia progression in children. Further work is required to clarify their mechanism of action and to optimise their de...
This study is a retrospective analysis to compare ocular biometry measurements of axial length in children with myopia using Myopia Master (OCULUS, Wetzlar, Germany) and Lenstar LS900 (HAAG-STREIT AG,...
Axial length measurements obtained with both instruments within a 3-week period were collected retrospectively. Measurements were visualized with a Bland-Altman plot. For statistical evaluation, a pai...
Sixty-one eyes from 31 myopic patients (59% male, 41% female) with a mean age of 11.34 ± 3.25 years (range: 6 - 18 years) were identified. Mean axial length was 24.7 mm (SD 1.29) with the Myopia Maste...
The axial length measured by Myopia Master and Lenstar LS900 did not differ significantly. Thus, previous values obtained with the Lenstar LS900 can be applied to assess myopia progression....
The META-Analysis of Pathologic Myopia Study group proposed a new classification system for myopic maculopathy (MM) with pathologic myopia (PM) defined as MM equal to/more serious than diffuse atrophy...
This study examined the optical impact of a DF contact lens during near viewing in a sample of habitual DF lens wearing children....
Seventeen myopic children aged 14 to 18 years who had completed 3 or 6 years of treatment with a DF contact lens (MiSight 1 Day; CooperVision, Inc., San Ramon, CA) were recruited and fit bilaterally w...
During near viewing, children wearing single-vision lenses accommodated on average to achieve approximate focus in the pupil center but, because of combined accommodative lag and negative spherical ab...
The DF contact lens did not alter the accommodative behavior of children. The treatment optics introduced myopic defocus and decreased the amount of hyperopically defocused light in the retinal image....
The rising prevalence of myopia among children and adolescents necessitates effective interventions to mitigate long-term risks, such as retinal detachment and macular degeneration. Traditional approa...